Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.68 |
| ▸ | MAPT | P10636 | 3/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | DGKA | P23743 | 1/20 | 0.55 |
| ▸ | PRKCA | P17252 | 1/20 | 0.54 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.54 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.54 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | PAM | P19021 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10536564 | 1.00 | LMNA (0.68) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL17866528 | 0.91 | LMNA (0.55) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL22033730 | 0.89 | LMNA (0.55) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL4433229 | 0.86 | LMNA (0.71) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL9631208 | 0.86 | LMNA (0.71) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL11147236 | 0.86 | LMNA (0.71) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL10947202 | 0.86 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL4740162 | 0.83 | LMNA (0.68) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL4787242 | 0.83 | LMNA (0.68) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL2702259 | 0.82 | MAPT (0.68) | LMNAMAPTMAPK1ALDH1A1DGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240102059-A1 | METHOD FOR MANUFACTURING TRIACYLGLYCEROLS ENRICHED EITHER IN PALMITIC ACID AT SN-2 POSITION OR OLEIC ACID AT SN-2 POSITION | NESTLE SA (CH) | 2024-03-28 | — | — | US | disclosed |
| US-20230189834-A1 | METHOD FOR MANUFACTURING SN-2 PALMITIC TRIACYLGLYCEROLS | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2023-06-22 | — | — | US | disclosed |
| US-20230159966-A1 | METHOD FOR MANUFACTURING SN-2 PALMITIC TRIACYLGLYCEROLS | NESTLE SA (CH) | 2023-05-25 | — | — | US | disclosed |
| US-11261401-B2 | Synthesis of 1,3-olein-2-palmitin (OPO) | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2022-03-01 | — | — | US | disclosed |
| US-20200190430-A1 | SYNTHESIS OF 1,3-OLEIN-2-PALMITIN (OPO) | NESTEC S.A. (CH) | 2020-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11261401-B2 | Synthesis of 1,3-olein-2-palmitin (OPO) | PLIN1, PLIN3, MOGAT2 | LMNA 4030/4885MAPT 1167/4885MAPK1 2258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.